SCHEMBL4055775

SCHEMBL4055775

c1cnc2[nH]c(CCC3CCCC3)nc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.36
TSHR P16473 1/20 0.34
RECQL P46063 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CDK1 P06493 3/20 0.33
CCNB1 P14635 3/20 0.33
CCNB2 O95067 2/20 0.33
GSK3A P49840 2/20 0.33
GSK3B P49841 2/20 0.33
CCNB3 Q8WWL7 2/20 0.33
METAP2 P50579 1/20 0.33
METAP1 P53582 1/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33
DAO P14920 2/20 0.33
PDGFRB P09619 1/20 0.32
PDGFRA P16234 1/20 0.32
RAB9A P51151 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4056218 0.98 LMNA (0.39) LMNATSHRRECQLSMN1; SMN2CDK1
SCHEMBL4046851 0.97 LMNA (0.34) LMNATSHRRECQLSMN1; SMN2CDK1
SCHEMBL4046172 0.94 METAP2 (0.35) LMNACDK1CCNB1CCNB2GSK3A
SCHEMBL4040136 0.84 AAK1 (0.43) CDK1CCNB1CCNB2GSK3AGSK3B
SCHEMBL4051351 0.83 PDE9A (0.42) LMNACDK1CCNB1CCNB2GSK3A
SCHEMBL4048041 0.81 PBK (0.40) CDK1CCNB1CCNB2GSK3AGSK3B
SCHEMBL4047661 0.77 PBK (0.42) CDK1CCNB1CCNB2GSK3AGSK3B
SCHEMBL4052252 0.73 KDM4C (0.41) CDK1CCNB1CCNB2GSK3AGSK3B
SCHEMBL4047123 0.72 METAP2 (0.36) METAP2METAP1
SCHEMBL4051241 0.70 PI4KA (0.45) CDK1CCNB1CCNB2GSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009029592-A1 HETEROBICYCLIC-SUBSTITUTED QUINOLONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2009-03-05 WO disclosed